Subscribe To
BSTG / Biostage, Inc. (BSTG) Interim CEO David Green on Q1 2022 Results - Earnings Call Transcript
BSTG News
By Seeking Alpha
June 24, 2022
Biostage Begins U.S. Uplisting IPO Rollout
Biostage has filed to raise capital via an uplisting IPO to Nasdaq. The firm is developing treatments for the various gastrointestinal system and airw more_horizontal
By Seeking Alpha
May 17, 2022
Biostage, Inc. (BSTG) Interim CEO David Green on Q1 2022 Results - Earnings Call Transcript
Biostage, Inc. (OTC:BSTG) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Peter Pellegrino - Interim Vice President of F more_horizontal